Indoprofen Composition for PGC-1α Expression in Muscle Cells

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need to develop compositions and methods that increase PGC-1α expression in mammalian cells, as reduced PGC-1α expression is associated with metabolic diseases such as obesity and decreased muscle function, particularly in obese or aging individuals.

Innovation Solution

A composition and method utilizing indoprofen, a pharmaceutically acceptable salt, or solvate thereof, to increase PGC-1α expression, convert muscle type II to type I, strengthen muscles, and enhance exercise performance by administering an effective amount to mammalian cells or subjects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If exercise is performed to increase PGC-1α expression and promote mitochondrial biogenesis, then oxidative muscle fiber proportion increases, but exercise capacity decreases in obese or aging individuals due to reduced baseline PGC-1α expression

Engineering Contradiction:
ImprovePGC-1α expression levelVSAvoidexercise capacity
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

Indoprofen acts as a chemical intermediary that mediates between the need for increased PGC-1α expression and the desire to improve exercise capacity. The compound directly activates PGC-1α expression without requiring actual exercise, thereby bridging the gap between metabolic improvement and physical performance in individuals who cannot exercise effectively due to obesity or aging.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention changes the biochemical parameter of PGC-1α expression levels through pharmacological intervention. By administering indoprofen, the expression level of PGC-1α is directly increased, altering the metabolic state of muscle cells from a low PGC-1α state (associated with obesity and aging) to a high PGC-1α state (associated with improved mitochondrial function and exercise capacity).

Inventive Principle:
Principle #35Parameter changes

2Reliability

If muscle type II is converted to muscle type I through exercise to increase oxidative capacity, then mitochondrial biogenesis is promoted, but the physical stress and time required for such exercise increases

Engineering Contradiction:
Improveoxidative muscle fiber proportionVSAvoidtime for exercise training
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

Indoprofen performs the action of increasing PGC-1α expression preliminarily, before actual exercise training would be needed. By pre-activating the molecular pathways responsible for mitochondrial biogenesis and oxidative fiber conversion, the compound prepares the muscle tissue to achieve these adaptations without requiring extensive training time, effectively shortcutting the natural time-dependent process.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The compound serves as a chemical intermediary that replaces the need for prolonged physical exercise. Instead of using mechanical stress from exercise to trigger PGC-1α expression over time, indoprofen chemically mediates the same outcome directly, converting muscle fiber types and promoting mitochondrial biogenesis in a time-efficient manner.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS10610515B2Composition including indoprofen and use thereof
Publication Date: 2020.04.07 SAMSUNG ELECTRONICS CO LTD
  • US10610515B2 patent drawing
  • US10610515B2 patent drawing
  • US10610515B2 patent drawing

AI summary

A method of increasing PGC-1α expression in a mammalian cell, the method comprising administering an effective amount of indoprofen, a pharmaceutically acceptable salt thereof, or a solvate thereof to the cell.